Abstract
The acylation of glycylglycine and its morpholide with 4,5-dichloroisothiazole-3-carbonyl chloride gave the corresponding N-(4,5-dichloroisothiazole-3-ylcarbonyl) derivatives. N-[5-(p-Tolyl)isoxazole-3-carbonyl] analogs were synthesized by acylation of glycylglycine and its morpholide with 5-(p-tolyl)isoxazole-3-carbonyl azide since treatment of the same substrates with 5-(p-tolyl)isoxazole-3-carbonyl resulted in the formation of mixtures of products. The reactions of glycylglycine and its morpholide with phenyl N-(4,5-dichloroisothiazol-3-yl)- and N-[(p-tolyl)isoxazol-3-yl]carbamates afforded derivatives containing an urea fragment. Some of the synthesized compounds showed antitumor activity and enhanced the antitumor effect of doxorubicin.
Similar content being viewed by others
REFERENCES
Grauer, A., Riechers, A., Ritter, S., and König, B., Chem. Eur. J., 2008, vol. 14, p. 8922. https://doi.org/10.1002/chem.200800432
Lam, L.H., Shimamura, T., Sakaguchi, K., Noguchi, K., Ishiyama, M., Fujimura, Yu., and Ukeda, H., Anal. Biochem., 2007, vol. 364, p. 104. https://doi.org/10.1016/j.ab.2007.02.017
Malipeddi, H. and Jambulingam, R., Int. J. Pharm. Sci. Rev. Res., 2013, vol. 21, p. 1.
Fedoreyeva, L.I., Kononenko, N.V., Baranova, E.N., Dilovarova, T.A., Smirnova, E.A., and Vanyushin, B.F., Biol. Bull., 2020, vol. 47, p. 364. https://doi.org/10.1134/S1062359020030036
Wang, J., Cooper, D.L., Zhan, W., Wu, D., He, H., Sun, S., Lovett, S.T., and Xu, B., Angew. Chem., Int. Ed., 2019, vol. 58, p. 10631. https://doi.org/10.1002/anie.201905230
Kulchitsky, V.A., Potkin, V.I., Zubenko, Yu.S., Chernov, A.N., Talabaev, M.V., Demidchik, Yu.E., Petkevich, S.K., Kazbanov, V.V., Gurinovich, T.A., Roeva, M.O., Grigoriev, D.G., Kletskov, A.V., and Kalunov, V.N., Med. Chem., 2012, vol. 8, p. 22. https://doi.org/10.2174/157340612799278298
Kletskov, A.V., Potkin, V.I., Kolesnik, I.A., Petkevich, S.K., Kvachonak, A.V., Dosina, M.O., Loiko, D.O., Larchenko, M.V., Pashkevich, S.G., and Kulchitsky, V.A., Nat. Prod. Commun., 2018, vol. 13, p. 1507. https://doi.org/10.1177/1934578X1801301124
Potkin, V.I., Petkevich, S.K., Kletskov, A.V., Zubenko, Yu.S., Kurman, P.V., Pashkevich, S.G., Gurinovich, T.A., and Kulchitskiy, V.A., Russ. J. Org. Chem., 2014, vol. 50, p. 1667. https://doi.org/10.1134/S1070428014110219
Kletskov, A.V., Bumagin, N.A., Zubkov, F.I., Grudinin, D.G., and Potkin, V.I., Synthesis, 2020, vol. 52, p. 159. https://doi.org/10.1055/s-00000084
Potkin, V.I., Kletskov, A.V., Petkevich, S.K., Pashkevich, S.G., Kazbanov, V.V., Denisov, A.A., and Kulchitsky, V.A., Heterocycl. Lett., 2015, vol. 5, p. 11. https://heteroletters.org/issue15/Paper-1.pdf
Pal’chikov, V.A., Russ. J. Org. Chem., 2013, vol. 49, p. 787. https://doi.org/10.1134/S1070428013060018
Gomez, J.D.C, Hagenbach, A., and Abram, U., Eur. J. Inorg. Chem., 2016, vol. 2016, p. 5427. https://doi.org/10.1002/ejic.201601039
Pietuch, A., Brückner, B.R., Schneider, D., Tarantola, M., Rosman, Ch., Sönnichsen, C., and Janshoff, A., Beilstein J. Nanotechnol., 2015, vol. 6, p. 223. https://doi.org/10.3762/bjnano.6.21
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare the absence of conflict of interest.
Additional information
Translated from Zhurnal Organicheskoi Khimii, 2021, Vol. 57, No. 10, pp. 1382–1392 https://doi.org/10.31857/S0514749221100037.
Rights and permissions
About this article
Cite this article
Kolesnik, I.A., Kletskov, A.V., Potkin, V.I. et al. Glycylglycine and Its Morpholide Derivatives Containing 5-(p-Tolyl)isoxazole and 4,5-Dichloroisothiazole Moieties. Russ J Org Chem 57, 1584–1591 (2021). https://doi.org/10.1134/S1070428021100031
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070428021100031